Literature DB >> 3440238

Predictors of survival after curative resection of carcinoma of the colon and rectum.

M R Griffin1, E J Bergstralh, R J Coffey, R W Beart, L J Melton.   

Abstract

Of 668 Rochester, Minnesota residents with colon or rectal cancer diagnosed from 1940 through 1979, 400 (60%) were operated on for cure and had a known disease stage. The influence of patient sex, age, and decade of diagnosis, disease stage, grade, site, and size, and the presence of obstruction or perforation were examined as prognostic factors for death, death from colorectal cancer, and cancer recurrence. In this population-based inception cohort, overall survival was independently associated with male sex (P = 0.0002), older age (P less than 0.001), and more advanced disease stage (P less than 0.001). Death due to colon cancer, on the other hand, was associated with disease stage (P less than 0.0001), more advanced grade (P = 0.016), and the presence of obstruction (P = 0.003). One hundred seven (27%) patients had a recurrence of their colon cancer. Seventy-one percent of recurrences were evident within the first 2 years and 91% by 5 years. Recurrence was associated with disease stage (P less than 0.0001), grade (P = 0.006), and the presence of perforation (P = 0.012).

Entities:  

Mesh:

Year:  1987        PMID: 3440238     DOI: 10.1002/1097-0142(19871101)60:9<2318::aid-cncr2820600934>3.0.co;2-b

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  46 in total

1.  Unfavorable effect of small tumor size on cause-specific survival in stage IIA colon cancer, a SEER-based study.

Authors:  Yuwei Wang; Changhua Zhuo; Debing Shi; Hongtu Zheng; Ye Xu; Weilie Gu; Sanjun Cai; Guoxiang Cai
Journal:  Int J Colorectal Dis       Date:  2014-11-13       Impact factor: 2.571

2.  p27 cell-cycle inhibitor is inversely correlated with lymph node metastases in right-sided colon cancer.

Authors:  D F Liu; K Ferguson; G S Cooper; W M Grady; J Willis
Journal:  J Clin Lab Anal       Date:  1999       Impact factor: 2.352

3.  Surveillance after curative resection of colorectal cancer.

Authors:  Adena Scheer; Rebecca Ann C Auer
Journal:  Clin Colon Rectal Surg       Date:  2009-11

Review 4.  Surveillance of patients following surgery with curative intent for colorectal cancer.

Authors:  Steven Gan; Katherine Wilson; Paul Hollington
Journal:  World J Gastroenterol       Date:  2007-07-28       Impact factor: 5.742

5.  Outcome after proctectomy for rectal cancer in Department of Veterans Affairs Hospitals: a report from the National Surgical Quality Improvement Program.

Authors:  W E Longo; K S Virgo; F E Johnson; T P Wade; A M Vernava; M A Phelan; W G Henderson; J Daley; S F Khuri
Journal:  Ann Surg       Date:  1998-07       Impact factor: 12.969

6.  Sporadic loss of leucocyte-function-associated antigen-3 (LFA-3) in colorectal carcinomas.

Authors:  K Koretz; P Schlag; P Möller
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1991

Review 7.  Pathologic prognostic factors for gastrointestinal cancer.

Authors:  T Ismail; M T Hallissey; J W Fielding
Journal:  World J Surg       Date:  1995 Mar-Apr       Impact factor: 3.352

8.  Thoracic recurrence in patients with curatively-resected colorectal cancer: incidence, risk factors, and value of chest CT as a postoperative surveillance tool.

Authors:  J H Lee; Chang Min Park; I Joo; Y J Suh; E J Hwang; H Kim; J M Goo
Journal:  Eur Radiol       Date:  2018-10-22       Impact factor: 5.315

9.  Comparison of colorectal and gastric cancer: survival and prognostic factors.

Authors:  Bijan Moghimi-Dehkordi; Azadeh Safaee; Mohammad R Zali
Journal:  Saudi J Gastroenterol       Date:  2009-01       Impact factor: 2.485

10.  Insufficient Lymph Node Sampling in Patients with Colorectal Cancer Perforation is Associated with an Adverse Oncological Outcome.

Authors:  Kotaro Sugawara; Yoshikuni Kawaguchi; Yukihiro Nomura; Daisuke Koike; Motoki Nagai; Nobutaka Tanaka
Journal:  World J Surg       Date:  2017-01       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.